Endocrine treatment near the end of life among older women with metastatic breast cancer: a nationwide cohort study
Máté Szilcz(Karolinska Institutet), Kristina Johnell(Karolinska Institutet), Amaia Calderón‐Larrañaga(Stockholm University), Jonas W. Wastesson(Karolinska Institutet), Henrik Lindman(Uppsala University), Lucas Morin(Inserm)
Cited by 1
Related Papers
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
|PLoS ONE|2009|504
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
|The Lancet|2000|343
Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [<sup>68</sup>Ga]ABY-025 Affibody PET/CT
|Theranostics|2015|269
First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the <sup>111</sup>In-ABY-025 Affibody Molecule
|Journal of Nuclear Medicine|2014|260